Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Health Lab
Why Many Older Patients with Low Risk Still Want Colorectal Cancer Screenings
A study of colonoscopy recipients finds mixed feelings about using age, life expectancy and risk calculators to guide screening. How doctors can steer the conversation.
Medicine at Michigan
New Subtype of Prostate Cancer
A new subtype occurs in 7 percent of patients
Health Lab
Major Strides in Pancreatic Cancer Give ‘Actual Reasons for Hope’
More funding, scientific insights and clinical advances have started to drive progress in this challenging disease, and researchers see potential for immunotherapy to revolutionize its future.
News Release
U-M cancer researcher awarded $6.5M Outstanding Investigator Award to explore precision oncology
As researchers gain more understanding of how to target cancer treatment to specific genetic markers, identifying the best, most “actionable” markers is crucial.
News Release
Rogel Cancer Center awarded $33.4M from NCI
The National Cancer Institute has awarded the University of Michigan Rogel Cancer Center a grant worth $33.4 million over five years. At the same time, the center’s designation as a “comprehensive cancer center” was renewed.
Health Lab
Breast Cancer Patients Report Heavy Financial Toll of Treatment
Read findings from Michigan Medicine study into breast cancer treatment costs, which reveals patients report significant financial burdens from cancer treatment.
Health Lab
Why Consistent Testing Methods Are Crucial for Liquid Biopsies
A new study helps set standards for RNA sequencing, improving standard practice and laying the foundation to move the field forward.
Health Lab
How Targeting Metabolism Can Defeat Cancer Stem Cells
New research explains why stem cells become resistant to cancer treatment and opens a clever new way to go after them.
Health Lab
Surgeons Influence Receipt of Genetic Testing After Breast Cancer Diagnosis
Surveys of patients and their surgeons showed genetic testing rates ranged from 26 to 72 percent, depending on the surgeon.
Health Lab
Researchers Pinpoint New Subtype of Prostate Cancer
Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting a precision medicine approach.
Health Lab
Two Simple Steps to Prevent Cervical Cancer
Learn how HPV, the virus that causes cervical cancer, is transmitted and two things you can do to prevent cervical cancer and other HPV associated cancers.
Health Lab
Genome’s Dark Matter Sheds Light on Prostate Cancer Challenge
Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.
Health Lab
A Cascade of Immune Processes Offers Insights to Triple-Negative Breast Cancer
Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.
Medicine at Michigan
Challenges and Opportunities
Philanthropy, internal funding can fill gaps when federal funding decreases
Medicine at Michigan
Rogel Cancer Center
Shaping the future of cancer care and research
